BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Berens AM, Akkina SR, Patel SA. Complications in facial Mohs defect reconstruction. Curr Opin Otolaryngol Head Neck Surg 2017;25:258-64. [PMID: 28509671 DOI: 10.1097/MOO.0000000000000375] [Cited by in Crossref: 11] [Cited by in F6Publishing: 1] [Article Influence: 2.8] [Reference Citation Analysis]
Number Citing Articles
1 Bunnell AM. The Facial Skin Defect: Preop to Postop. Atlas Oral Maxillofac Surg Clin North Am 2020;28:1-5. [PMID: 32008703 DOI: 10.1016/j.cxom.2019.11.006] [Reference Citation Analysis]
2 Balakirski G, Felcht M, Bayer H, Schmitt L. Analyse des Status quo der perioperativen Antibiotikaprophylaxe in der Dermatochirurgie in Deutschland: Ergebnisse der DESSI-Studie. J Dtsch Dermatol Ges 2019;17:703-15. [PMID: 31364303 DOI: 10.1111/ddg.13864_g] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
3 Balakirski G, Felcht M, Bayer H, Schmitt L. Analysis of the status quo of perioperative antibiotic prophylaxis in dermatosurgery in Germany: results of the DESSI-study. J Dtsch Dermatol Ges 2019;17:703-13. [PMID: 31124600 DOI: 10.1111/ddg.13864] [Reference Citation Analysis]
4 Rabinowits G, Migden MR, Schlesinger TE, Ferris RL, Freeman M, Guild V, Koyfman S, Pavlick AC, Swanson N, Wolf GT, Dinehart SM. Evidence-Based Consensus Recommendations for the Evolving Treatment of Patients with High-Risk and Advanced Cutaneous Squamous Cell Carcinoma. JID Innov 2021;1:100045. [PMID: 34909742 DOI: 10.1016/j.xjidi.2021.100045] [Reference Citation Analysis]
5 Ghetti G, D'Avella MC, Pradelli L. Preliminary Cost-Effectiveness and Cost-Utility Analysis of Cemiplimab in Patients with Advanced Cutaneous Squamous Cell Carcinoma in Italy. Clinicoecon Outcomes Res 2021;13:121-33. [PMID: 33603419 DOI: 10.2147/CEOR.S295605] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]